학술논문
A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia
Document Type
Letter
Author
Source
In: Haematologica . (Haematologica, June 2022, 107(6):1454-1459)
Subject
Language
English
ISSN
15928721
03906078
03906078